How fast will I lose weight on GLP-1s and is it sustainable?

Short answer

• Many people see meaningful weight loss within the first 3 months on GLP‑1–class drugs, and the biggest losses usually occur in the first 6–12 months. Typical trial results range from modest (≈5–10%) to very large (≈15–25%) percent body‑weight reductions depending on the drug, dose, and how long you take it.
• GLP‑1s are very effective while you keep taking them, but stopping the drug commonly leads to partial or full weight regain unless lifestyle and metabolic changes are firmly established. In other words: effective, but usually a long‑term therapy rather than a “one‑time cure.”

What to expect (typical timelines and amounts)

• First 3 months: appetite drops and many people lose several percent of body weight (often the steepest decline).
• 6 months: many people have lost around 5–15% of baseline weight (wide variation).
• 9–12 months and beyond: higher doses / drugs with stronger effects show larger average losses — clinical trials report averages roughly:
  • Semaglutide (Wegovy) — commonly ~10–15% body weight at ~68 weeks in trials.
  • Tirzepatide (Zepbound for weight; Mounjaro for diabetes) — some trials reported average losses up to ~20–25% at ~72 weeks with the highest doses.
  • Liraglutide (Saxenda) — smaller average losses (roughly mid‑single digits to low teens over ~1 year in trials). Note: those are averages; individual results vary a lot.

Why results vary

• Starting weight, dose reached, how strictly you follow diet/exercise advice, other medications, metabolic rate, and genetics all change speed and amount of weight loss.
• Side effects (nausea, GI upset) can suppress appetite early and affect how quickly you lose weight.
• Differences between drugs matter: tirzepatide has shown larger average losses than semaglutide in head‑to‑head trials; liraglutide is less potent.

Sustainability — what the evidence shows

• Trials that stop the drug or switch to placebo show weight regain over months to years. Continued treatment generally preserves weight loss.
• Sustainable long‑term success usually combines medication plus permanent behavior changes (food choices, activity, sleep, stress, medical management).
• Expect that many people will need ongoing treatment (or another long‑term strategy) to keep the weight off.

Safety and practical points

• GLP‑1s require medical supervision. Common side effects: nausea, diarrhea, constipation, decreased appetite. Rare but serious concerns include pancreatitis, gallstones, and possible thyroid C‑cell tumor signals in rodents (discuss with your clinician).
• They may be contraindicated in people with a personal/family history of medullary thyroid carcinoma or MEN2.
• If you could become pregnant, discuss this carefully — these drugs are not recommended in pregnancy.
• Cost, insurance coverage, and access are common barriers; many prescriptions require prior authorization.

Brands and services (examples)

• Wegovy (semaglutide) — FDA‑approved for weight loss, strong evidence for 10–15% average loss at ~1 year. Weekly injection.
• Zepbound (tirzepatide) — FDA‑approved for weight loss; trials showed larger average losses (up to ~20–25% with higher doses). Weekly injection.
• Saxenda (liraglutide) — FDA‑approved for weight loss; less potent than semaglutide/tirzepatide but an option for some. Daily injection.
• Ozempic (semaglutide) and Mounjaro (tirzepatide) are diabetes products that are sometimes used off‑label for weight loss; dosing and approval differ.
• For medical management, look for a board‑certified obesity medicine specialist or multidisciplinary weight‑management clinic. The Obesity Medicine Association has a “Find a Provider” tool. Also consider structured programs (diabetes prevention programs and intensive lifestyle programs) alongside medication.

Next steps

• Talk with a clinician familiar with obesity medicine to review your medical history, goals, and which medicine (if any) fits you best.
• Ask about expected timeline, how success will be measured, side‑effect management, monitoring, and plan for long‑term maintenance.
• If you want, tell me your current weight, history of weight‑loss attempts, and any medical conditions or medications and I can give a more personalized expectation and list of questions to take to your clinician.